Journal
DRUG DISCOVERY TODAY
Volume 18, Issue 1-2, Pages 99-104Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2012.08.007
Keywords
-
Categories
Funding
- Association of Cancer Research 'ARC'
Ask authors/readers for more resources
In the past few years, the growth of nanometric size drug delivery systems (DDS) has burst into challenging innovations enabling real progresses to achieve oral delivery of anticancer drugs. DDS, such as polymeric nanoparticles, micelles, dendrimers and lipid-based formulations enable physico-chemical properties of cytotoxic agents to be improved and oral bioavailability to be enhanced. In this review we highlight current DDS used for the oral delivery of anticancer drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available